Radiopharmaceuticals Markets, 2025 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 5, 2019--
The “Global Radiopharmaceuticals Market - Products and Applications” report has been added to ResearchAndMarkets.com’s offering.
Overall market for Radiopharmaceuticals in 2019 is expected to touch US$6.1 billion.
The report reviews, analyzes and projects the global Radiopharmaceuticals market for the period 2016-2025 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2018 through 2025.
SPECT Radioisotopes constitute the single largest product type in global radiopharmaceuticals market, demand for which is expected to reach US$2.7 billion in 2019 while Beta Emitters is projected the fastest growing Radiopharmaceuticals product type globally during the analysis period 2018-2025 with a CAGR of 13.7%.
The rising prevalence of cancer and cardiovascular diseases are the main factors driving the radiopharmaceuticals market. Technological advancement, elevated healthcare expenditure, prevalence of chronic ailments, increasing geriatric population, rising awareness of radiopharmaceuticals applications in disease treatment, poor dietary habits, unhealthy lifestyle and increased awareness about the benefits of targeted alpha therapy are some of the other key factors fueling the radiopharmaceuticals market.
Research Findings & Coverage:
Key Market Trends
Key Business and Product Trends
Key Global Players
For more information about this report visit https://www.researchandmarkets.com/r/ids6pv
View source version on businesswire.com:https://www.businesswire.com/news/home/20191105005647/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/05/2019 07:50 AM/DISC: 11/05/2019 07:50 AM